174 related articles for article (PubMed ID: 9987705)
1. Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers.
Hebert MF; Fisher RM; Marsh CL; Dressler D; Bekersky I
J Clin Pharmacol; 1999 Jan; 39(1):91-6. PubMed ID: 9987705
[TBL] [Abstract][Full Text] [Related]
2. Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers.
Hebert MF; Park JM; Chen YL; Akhtar S; Larson AM
J Clin Pharmacol; 2004 Jan; 44(1):89-94. PubMed ID: 14681346
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus oral bioavailability doubles with coadministration of ketoconazole.
Floren LC; Bekersky I; Benet LZ; Mekki Q; Dressler D; Lee JW; Roberts JP; Hebert MF
Clin Pharmacol Ther; 1997 Jul; 62(1):41-9. PubMed ID: 9246018
[TBL] [Abstract][Full Text] [Related]
4. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
[TBL] [Abstract][Full Text] [Related]
5. The effect of rifampin on the pharmacokinetics of oral and intravenous ondansetron.
Villikka K; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 1999 Apr; 65(4):377-81. PubMed ID: 10223773
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
Lau YY; Okochi H; Huang Y; Benet LZ
Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
[TBL] [Abstract][Full Text] [Related]
7. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.
Fromm MF; Busse D; Kroemer HK; Eichelbaum M
Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction.
Hebert MF; Roberts JP; Prueksaritanont T; Benet LZ
Clin Pharmacol Ther; 1992 Nov; 52(5):453-7. PubMed ID: 1424418
[TBL] [Abstract][Full Text] [Related]
9. Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats.
Hashimoto Y; Sasa H; Shimomura M; Inui K
Pharm Res; 1998 Oct; 15(10):1609-13. PubMed ID: 9794505
[TBL] [Abstract][Full Text] [Related]
10. Effect of lansoprazole and rabeprazole on tacrolimus pharmacokinetics in healthy volunteers with CYP2C19 mutations.
Itagaki F; Homma M; Yuzawa K; Nishimura M; Naito S; Ueda N; Ohkohchi N; Kohda Y
J Pharm Pharmacol; 2004 Aug; 56(8):1055-9. PubMed ID: 15285851
[TBL] [Abstract][Full Text] [Related]
11. Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite.
Zheng HX; Huang Y; Frassetto LA; Benet LZ
Clin Pharmacol Ther; 2009 Jan; 85(1):78-85. PubMed ID: 18843263
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers.
Hulskotte E; Gupta S; Xuan F; van Zutven M; O'Mara E; Feng HP; Wagner J; Butterton J
Hepatology; 2012 Nov; 56(5):1622-30. PubMed ID: 22576324
[TBL] [Abstract][Full Text] [Related]
13. Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction.
Westphal K; Weinbrenner A; Zschiesche M; Franke G; Knoke M; Oertel R; Fritz P; von Richter O; Warzok R; Hachenberg T; Kauffmann HM; Schrenk D; Terhaag B; Kroemer HK; Siegmund W
Clin Pharmacol Ther; 2000 Oct; 68(4):345-55. PubMed ID: 11061574
[TBL] [Abstract][Full Text] [Related]
14. Concomitant clotrimazole therapy more than doubles the relative oral bioavailability of tacrolimus.
Vasquez EM; Shin GP; Sifontis N; Benedetti E
Ther Drug Monit; 2005 Oct; 27(5):587-91. PubMed ID: 16175131
[TBL] [Abstract][Full Text] [Related]
15. The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects.
Möller A; Iwasaki K; Kawamura A; Teramura Y; Shiraga T; Hata T; Schäfer A; Undre NA
Drug Metab Dispos; 1999 Jun; 27(6):633-6. PubMed ID: 10348790
[TBL] [Abstract][Full Text] [Related]
16. The colon displays an absorptive capacity of tacrolimus.
Nishi K; Ishii T; Wada M; Amae S; Sano N; Nio M; Hayashi Y
Transplant Proc; 2004 Mar; 36(2):364-6. PubMed ID: 15050160
[TBL] [Abstract][Full Text] [Related]
17. The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers.
Pentikis HS; Connolly M; Trapnell CB; Forbes WP; Bettenhausen DK
Pharmacotherapy; 2007 Oct; 27(10):1361-9. PubMed ID: 17896891
[TBL] [Abstract][Full Text] [Related]
18. The Effect of P-Glycoprotein Inhibition and Activation on the Absorption and Serum Levels of Cyclosporine and Tacrolimus in Rats.
Yigitaslan S; Erol K; Cengelli C
Adv Clin Exp Med; 2016; 25(2):237-42. PubMed ID: 27627555
[TBL] [Abstract][Full Text] [Related]
19. Effect of rifampin on the pharmacokinetics of bosutinib, a dual Src/Abl tyrosine kinase inhibitor, when administered concomitantly to healthy subjects.
Abbas R; Boni J; Sonnichsen D
Drug Metab Pers Ther; 2015 Mar; 30(1):57-63. PubMed ID: 25803093
[TBL] [Abstract][Full Text] [Related]
20. Effect of rifampin on plasma concentrations of mefloquine in healthy volunteers.
Ridtitid W; Wongnawa M; Mahatthanatrakul W; Chaipol P; Sunbhanich M
J Pharm Pharmacol; 2000 Oct; 52(10):1265-9. PubMed ID: 11092571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
